 | • レポートコード：GIR-105X09158 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、105ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、イグラチモドのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。イグラチモドの種類別市場規模（14個/箱、100個/箱）、用途別市場規模（抗リウマチ薬、免疫調節薬、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・イグラチモドの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Simcere Pharmaceutical、Toyama Chemical、Eisai ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：14個/箱、100個/箱 ・用途別分析2016年-2026年：抗リウマチ薬、免疫調節薬、その他 ・イグラチモドの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・イグラチモドのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・イグラチモドのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・イグラチモドの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・イグラチモドの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Iguratimod market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Iguratimod size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Iguratimod market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Iguratimod market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
14 Pcs/Box
100 Pcs/Box
Market segment by Application can be divided into
Antirheumatic
Immunoregulation
Other
The key market players for global Iguratimod market are listed below:
Simcere Pharmaceutical
Toyama Chemical
Eisai
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Iguratimod Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Iguratimod Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 14 Pcs/Box
1.2.3 100 Pcs/Box
1.3 Market Analysis by Application
1.3.1 Overview: Global Iguratimod Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Antirheumatic
1.3.3 Immunoregulation
1.3.4 Other
1.4 Global Iguratimod Market Size & Forecast
1.4.1 Global Iguratimod Sales in Value (2016-2026))
1.4.2 Global Iguratimod Sales in Volume (2016-2026)
1.4.3 Global Iguratimod Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Iguratimod Production Capacity Analysis
1.5.1 Global Iguratimod Total Production Capacity (2016-2026)
1.5.2 Global Iguratimod Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Iguratimod Market Drivers
1.6.2 Iguratimod Market Restraints
1.6.3 Iguratimod Trends Analysis
2 Manufacturers Profiles
2.1 Simcere Pharmaceutical
2.1.1 Simcere Pharmaceutical Details
2.1.2 Simcere Pharmaceutical Major Business
2.1.3 Simcere Pharmaceutical Iguratimod Product and Services
2.1.4 Simcere Pharmaceutical Iguratimod Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Toyama Chemical
2.2.1 Toyama Chemical Details
2.2.2 Toyama Chemical Major Business
2.2.3 Toyama Chemical Iguratimod Product and Services
2.2.4 Toyama Chemical Iguratimod Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Eisai
2.3.1 Eisai Details
2.3.2 Eisai Major Business
2.3.3 Eisai Iguratimod Product and Services
2.3.4 Eisai Iguratimod Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Iguratimod Sales by Manufacturer
3.1 Global Iguratimod Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Iguratimod Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Iguratimod
3.4 Market Concentration Rate
3.4.1 Top 3 Iguratimod Manufacturer Market Share
3.4.2 Top 6 Iguratimod Manufacturer Market Share
3.5 Global Iguratimod Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Iguratimod Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Iguratimod Market Size by Region
4.1.1 Global Iguratimod Sales in Volume by Region (2016-2026)
4.1.2 Global Iguratimod Revenue by Region (2016-2026)
4.2 North America Iguratimod Revenue (2016-2026)
4.3 Europe Iguratimod Revenue (2016-2026)
4.4 Asia-Pacific Iguratimod Revenue (2016-2026)
4.5 South America Iguratimod Revenue (2016-2026)
4.6 Middle East and Africa Iguratimod Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Iguratimod Sales in Volume by Type (2016-2026)
5.2 Global Iguratimod Revenue by Type (2016-2026)
5.3 Global Iguratimod Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Iguratimod Sales in Volume by Application (2016-2026)
6.2 Global Iguratimod Revenue by Application (2016-2026)
6.3 Global Iguratimod Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Iguratimod Sales by Type (2016-2026)
7.2 North America Iguratimod Sales by Application (2016-2026)
7.3 North America Iguratimod Market Size by Country
7.3.1 North America Iguratimod Sales in Volume by Country (2016-2026)
7.3.2 North America Iguratimod Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Iguratimod Sales by Type (2016-2026)
8.2 Europe Iguratimod Sales by Application (2016-2026)
8.3 Europe Iguratimod Market Size by Country
8.3.1 Europe Iguratimod Sales in Volume by Country (2016-2026)
8.3.2 Europe Iguratimod Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Iguratimod Sales by Type (2016-2026)
9.2 Asia-Pacific Iguratimod Sales by Application (2016-2026)
9.3 Asia-Pacific Iguratimod Market Size by Region
9.3.1 Asia-Pacific Iguratimod Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Iguratimod Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Iguratimod Sales by Type (2016-2026)
10.2 South America Iguratimod Sales by Application (2016-2026)
10.3 South America Iguratimod Market Size by Country
10.3.1 South America Iguratimod Sales in Volume by Country (2016-2026)
10.3.2 South America Iguratimod Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Iguratimod Sales by Type (2016-2026)
11.2 Middle East & Africa Iguratimod Sales by Application (2016-2026)
11.3 Middle East & Africa Iguratimod Market Size by Country
11.3.1 Middle East & Africa Iguratimod Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Iguratimod Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Iguratimod Typical Distributors
12.3 Iguratimod Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Iguratimod Revenue by Type, (USD Million), 2021-2026
Table 2. Global Iguratimod Revenue by Application, (USD Million), 2021-2026
Table 3. Simcere Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Simcere Pharmaceutical Major Business
Table 5. Simcere Pharmaceutical Iguratimod Product and Services
Table 6. Simcere Pharmaceutical Iguratimod Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Toyama Chemical Basic Information, Manufacturing Base and Competitors
Table 8. Toyama Chemical Major Business
Table 9. Toyama Chemical Iguratimod Product and Services
Table 10. Toyama Chemical Iguratimod Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Eisai Basic Information, Manufacturing Base and Competitors
Table 12. Eisai Major Business
Table 13. Eisai Iguratimod Product and Services
Table 14. Eisai Iguratimod Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Global Iguratimod Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 16. Global Iguratimod Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 17. Market Position of Manufacturers in Iguratimod, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 18. Global Iguratimod Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 19. Head Office and Iguratimod Production Site of Key Manufacturer
Table 20. Global Iguratimod Sales by Region (2016-2021e) & (K Pcs)
Table 21. Global Iguratimod Sales by Region (2021-2026) & (K Pcs)
Table 22. Global Iguratimod Revenue by Region (2016-2021e) & (USD Million)
Table 23. Global Iguratimod Revenue by Region (2021-2026) & (USD Million)
Table 24. Global Iguratimod Sales by Type (2016-2021e) & (K Pcs)
Table 25. Global Iguratimod Sales by Type (2021-2026) & (K Pcs)
Table 26. Global Iguratimod Revenue by Type (2016-2021e) & (USD Million)
Table 27. Global Iguratimod Revenue by Type (2021-2026) & (USD Million)
Table 28. Global Iguratimod Price by Type (2016-2021e) & (USD/Pcs)
Table 29. Global Iguratimod Price by Type (2021-2026) & (USD/Pcs)
Table 30. Global Iguratimod Sales by Application (2016-2021e) & (K Pcs)
Table 31. Global Iguratimod Sales by Application (2021-2026) & (K Pcs)
Table 32. Global Iguratimod Revenue by Application (2016-2021e) & (USD Million)
Table 33. Global Iguratimod Revenue by Application (2021-2026) & (USD Million)
Table 34. Global Iguratimod Price by Application (2016-2021e) & (USD/Pcs)
Table 35. Global Iguratimod Price by Application (2021-2026) & (USD/Pcs)
Table 36. North America Iguratimod Sales by Country (2016-2021e) & (K Pcs)
Table 37. North America Iguratimod Sales by Country (2021-2026) & (K Pcs)
Table 38. North America Iguratimod Revenue by Country (2016-2021e) & (USD Million)
Table 39. North America Iguratimod Revenue by Country (2021-2026) & (USD Million)
Table 40. North America Iguratimod Sales by Type (2016-2021e) & (K Pcs)
Table 41. North America Iguratimod Sales by Type (2021-2026) & (K Pcs)
Table 42. North America Iguratimod Sales by Application (2016-2021e) & (K Pcs)
Table 43. North America Iguratimod Sales by Application (2021-2026) & (K Pcs)
Table 44. Europe Iguratimod Sales by Country (2016-2021e) & (K Pcs)
Table 45. Europe Iguratimod Sales by Country (2021-2026) & (K Pcs)
Table 46. Europe Iguratimod Revenue by Country (2016-2021e) & (USD Million)
Table 47. Europe Iguratimod Revenue by Country (2021-2026) & (USD Million)
Table 48. Europe Iguratimod Sales by Type (2016-2021e) & (K Pcs)
Table 49. Europe Iguratimod Sales by Type (2021-2026) & (K Pcs)
Table 50. Europe Iguratimod Sales by Application (2016-2021e) & (K Pcs)
Table 51. Europe Iguratimod Sales by Application (2021-2026) & (K Pcs)
Table 52. Asia-Pacific Iguratimod Sales by Region (2016-2021e) & (K Pcs)
Table 53. Asia-Pacific Iguratimod Sales by Region (2021-2026) & (K Pcs)
Table 54. Asia-Pacific Iguratimod Revenue by Region (2016-2021e) & (USD Million)
Table 55. Asia-Pacific Iguratimod Revenue by Region (2021-2026) & (USD Million)
Table 56. Asia-Pacific Iguratimod Sales by Type (2016-2021e) & (K Pcs)
Table 57. Asia-Pacific Iguratimod Sales by Type (2021-2026) & (K Pcs)
Table 58. Asia-Pacific Iguratimod Sales by Application (2016-2021e) & (K Pcs)
Table 59. Asia-Pacific Iguratimod Sales by Application (2021-2026) & (K Pcs)
Table 60. South America Iguratimod Sales by Country (2016-2021e) & (K Pcs)
Table 61. South America Iguratimod Sales by Country (2021-2026) & (K Pcs)
Table 62. South America Iguratimod Revenue by Country (2016-2021e) & (USD Million)
Table 63. South America Iguratimod Revenue by Country (2021-2026) & (USD Million)
Table 64. South America Iguratimod Sales by Type (2016-2021e) & (K Pcs)
Table 65. South America Iguratimod Sales by Type (2021-2026) & (K Pcs)
Table 66. South America Iguratimod Sales by Application (2016-2021e) & (K Pcs)
Table 67. South America Iguratimod Sales by Application (2021-2026) & (K Pcs)
Table 68. Middle East & Africa Iguratimod Sales by Country (2016-2021e) & (K Pcs)
Table 69. Middle East & Africa Iguratimod Sales by Country (2021-2026) & (K Pcs)
Table 70. Middle East & Africa Iguratimod Revenue by Country (2016-2021e) & (USD Million)
Table 71. Middle East & Africa Iguratimod Revenue by Country (2021-2026) & (USD Million)
Table 72. Middle East & Africa Iguratimod Sales by Type (2016-2021e) & (K Pcs)
Table 73. Middle East & Africa Iguratimod Sales by Type (2021-2026) & (K Pcs)
Table 74. Middle East & Africa Iguratimod Sales by Application (2016-2021e) & (K Pcs)
Table 75. Middle East & Africa Iguratimod Sales by Application (2021-2026) & (K Pcs)
Table 76. Direct Channel Pros & Cons
Table 77. Indirect Channel Pros & Cons
Table 78. Iguratimod Typical Distributors
Table 79. Iguratimod Typical Customers
List of Figures
Figure 1. Iguratimod Picture
Figure 2. Global Iguratimod Sales Market Share by Type in 2020
Figure 3. 14 Pcs/Box
Figure 4. 100 Pcs/Box
Figure 5. Global Iguratimod Sales Market Share by Application in 2020
Figure 6. Antirheumatic
Figure 7. Immunoregulation
Figure 8. Other
Figure 9. Global Iguratimod Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 10. Global Iguratimod Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Iguratimod Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Iguratimod Sales (2016-2026) & (K Pcs)
Figure 31. Global Iguratimod Production Capacity (2016-2026) & (K Pcs)
Figure 32. Global Iguratimod Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Iguratimod Market Drivers
Figure 34. Iguratimod Market Restraints
Figure 35. Iguratimod Market Trends
Figure 36. Global Iguratimod Sales Market Share by Manufacturer in 2020
Figure 37. Global Iguratimod Revenue Market Share by Manufacturer in 2020
Figure 38. Iguratimod Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Iguratimod Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Iguratimod Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Iguratimod Sales Market Share by Region (2016-2026)
Figure 42. Global Iguratimod Revenue Market Share by Region (2016-2026)
Figure 43. North America Iguratimod Revenue (2016-2026) & (USD Million)
Figure 44. Europe Iguratimod Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Iguratimod Revenue (2016-2026) & (USD Million)
Figure 46. South America Iguratimod Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Iguratimod Revenue (2016-2026) & (USD Million)
Figure 48. Global Iguratimod Sales Market Share by Type (2016-2026)
Figure 49. Global Iguratimod Revenue Market Share by Type (2016-2026)
Figure 50. Global Iguratimod Price by Type (2016-2026) & (USD/Pcs)
Figure 51. Global Iguratimod Sales Market Share by Application (2016-2026)
Figure 52. Global Iguratimod Revenue Market Share by Application (2016-2026)
Figure 53. Global Iguratimod Price by Application (2016-2026) & (USD/Pcs)
Figure 54. North America Iguratimod Sales Market Share by Country (2016-2026)
Figure 55. North America Iguratimod Revenue Market Share by Country (2016-2026)
Figure 56. North America Iguratimod Sales Market Share by Type (2016-2026)
Figure 57. North America Iguratimod Sales Market Share by Application (2016-2026)
Figure 58. Europe Iguratimod Sales Market Share by Country (2016-2026)
Figure 59. Europe Iguratimod Revenue Market Share by Country (2016-2026)
Figure 60. Europe Iguratimod Sales Market Share by Type (2016-2026)
Figure 61. Europe Iguratimod Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Iguratimod Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Iguratimod Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Iguratimod Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Iguratimod Sales Market Share by Application (2016-2026)
Figure 66. South America Iguratimod Sales Market Share by Country (2016-2026)
Figure 67. South America Iguratimod Revenue Market Share by Country (2016-2026)
Figure 68. South America Iguratimod Sales Market Share by Type (2016-2026)
Figure 69. South America Iguratimod Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Iguratimod Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Iguratimod Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Iguratimod Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Iguratimod Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source